Orexin a suppresses the growth of rat C6 glioma cells via a caspase-dependent mechanism

Journal of Molecular Neuroscience

Volumn 48, Issue 3, 2012, Pages 706-712

  Biegańska, Kaja ^a,b   Sokołowska, Paulina ^a   Jöhren, Olaf ^c   Zawilska, Jolanta B ^a,b  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

C6 glioma cells; Cell death; Hypocretin; Orexin; Orexin receptors

Indexed keywords

BENZYLOXY CARBONYL VALINE ALANINE ASPARAGINE FLUOROMETHYLKETONE; CASPASE; KETONE DERIVATIVE; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; THYMIDINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURVIVAL; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA CELL; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CASPASE INHIBITORS; CASPASES; CELL DIVISION; CELL LINE, TUMOR; GLIOMA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM PROTEINS; NEUROPEPTIDES; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RNA, MESSENGER; RNA, NEOPLASM;

MUS; RATTUS;

EID: 84868212477     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9799-0     Document Type: Article

References (40)

1. Ammoun S, Holmqvist T, Shariatmadari R, Oonk HB, Detheux M, Parmentier M, Åkerman KEO, Kukkonen JP (2003) Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharmacol Exp Ther 305:507-514 (Pubitemid 36459164)
2. Ammoun S, Lindholm D, Woolz H, Åkerman KEO, Kukkonen JP (2006) G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38-/stress-activated protein kinase. J Biol Chem 281:834-842
3. Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili- Fahadan P, Richardson KA (2010) Lateral hypothalamic orexin/ hypocretin neurons: a role in reward-seeking and addiction. Brain Res 1314:74-90
4. Auer RN, Del Maestro RF, Anderson R (1981) A simple and reproducible experimental in vivo glioma model. Can J Neurol Sci 8:325-331 (Pubitemid 12242587)
5. Benda P, Lightbody J, Sato G, Levine L (1968) Differentiated rat glial cell strain in tissue culture. Science 161(3839):370-371
6. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-451 (Pubitemid 29402482)
7. Cimini A, Ippoliti R (2011) Innovative therapies against human glioblastoma multiforme. ISRN Oncol 2011:787490
8. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205-219 (Pubitemid 38167313)
9. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95:322-327 (Pubitemid 28103952)
10. El Firar A, Voisin T, Rouyer-Fessard C, Ostuni MA, Convineau A, Laburthe M (2009) Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis. FASEB J 23:4069-4080
11. Heinonen MV, Purhonen AK, Mäkelä KA, Herzig KH (2008) Functions of orexins in peripheral tissues. Acta Physiol (Oxf) 192:471-485 (Pubitemid 351322731)
12. Henriksson R, Asklund T, Poulse HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol 104:639-646
13. Higuchi R, Fockler C, Dollinger G, Watson R (1993) Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 11:1026-1030 (Pubitemid 23254023)
14. Johnson CE, Huang YY, Parrish AB, Smith MI, Vaughn AE, Zhang Q, Wright KM, Van Dyke T, Wechsler-Reya RJ, Kornbluth S, Deshmukh M (2007) Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci USA 104:20820-20825
15. Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P (2001) Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142:3324-3331 (Pubitemid 32681736)
16. Kagerer SM, Jöhren O (2010) Interactions of orexins/hypocretins with adrenocortical functions. Acta Physiol (Oxf) 198:361-371
17. Kodadek T, Cai D (2010) Chemistry and biology of orexin signaling. Mol Biosyst 8:1366-1375
18. Korczyński W, Ceregrzyn M, Matyjek R, Kato I, Kuwahara A, Woliński J, Zabielski R (2006) Central and local (enteric action) of orexins. J Physiol Pharmacol 57:17-42 (Pubitemid 46548799)
19. Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KEO (2002) Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol 283:1567-1591
20. Laburthe M, Voisin T, El Firar A (2010) Orexins/hypocretins and orexin receptors in apoptosis: a mini-review. Acta Physiol (Oxf) 198:393-402
21. Lim SK, Alcantara Llaguno SR, McKay RM, Parada LF (2011) Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models. BMB Rep 44:158-164
22. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376 (Pubitemid 29380571)
23. Matsuki T, Sakurai T (2008) Orexins and orexin receptors: from molecules to integrative physiology. Results Probl Cell Differ 46:27-55
24. Mazzocchi G,Malendowicz LK, Gottardo L, Aragona F, Nussdorfer GG (2001) Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade. J Clin Endocrinol Metab 86:778-782 (Pubitemid 32207496)
25. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K (1999) Distribution of orexin neurons in the adult rat brain. Brain Res 827:243-260 (Pubitemid 29222929)
26. Nishino S (2007) Clinical and neurobiological aspects of narcolepsy. Sleep Med 8:373-399 (Pubitemid 46722263)
27. Okumura T, Nozu T (2011) Role of brain orexin in the pathophysiology of functional gastrointestinal disorders. J Gastroenterol Hepatol 26(Suppl 3):61-66
28. Putula J, Turunen PM, Jäntti MH, Ekholm ME, Kukkonen JP (2011) Agonist ligand discrimination by the two orexin receptors depends on the expression system. Neurosci Lett 494:57-60
29. Rouet-Benzineb P, Rouyer-Fessard C, Jarry A, Avondo V, Pouzet C, Yanagisawa M, Laboisse C, Laburthe M, Voisin T (2004) Orexins acting at native OX1 receptor in colon cancer and neuroblastoma cells or at recombinant OX1 receptor suppress cell growth by inducing apoptosis. J Biol Chem 279:45875-45886 (Pubitemid 39491580)
30. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585 (Pubitemid 28101119)
31. Sokołowska P, Urbańska A, Namiecińska M, Biegańska K, Zawilska JB (2012) Orexins promote survival of rat cortical neurons. Neurosci Lett 506:303-306
32. Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG (2006) Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev 58:46-57
33. Tang J, Chen J, Ramanjaneya M, Punn A, Conner AC, Randeva HS (2008) The signaling profile of recombinant human orexin-2 receptor. Cell Sign 20:1651-1661
34. Thannickal TC, Siegel JM, Nienhuis R, Moore RY (2003) Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 13:340-351 (Pubitemid 36975824)
35. Urbańska A, Sokołowska P, Woldan-Tambor A, Biegańska K, Brix B, Jöhren O, Namiecińska M, Zawilska JB (2012) Orexins/hypocretins acting at Gi protein-coupled OX2 receptors inhibit cyclic AMP synthesis in primary neuronal cultures. J Mol Neurosci 46:10-17
36. Voisin T, Rouet-Benzineb P, Reuter N, Laburthe M (2003) Orexins and their receptors: structural aspects and role in peripheral tissues. Cell Mol Life Sci 60:72-87 (Pubitemid 36223118)
37. Voisin T, El Firar A, Avondo V, Laburthe M (2006) Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor. Endocrinology 147:4977-4984 (Pubitemid 44402205)
38. Voisin T, El Firar A, Fasseu M, Rouyer-Fessard C, Descatoire V, Walker F, Paradis V, Bedossa P, Henin D, Lehy T, Laburthe M (2011) Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis. Cancer Res 71:3341-3351
39. Xu T-R, Ward RJ, Pediani JD, Milligan G (2011) The orexin OX1 receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands. Biochem J 439:171-183
40. Ziolkowska A, Spinazzi R, Albertin G, Nowak M, Malendowicz LK, Tortorella C, Nussdorfer GG (2005) Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor. Int J Mol Med 15:847-852